SCHEMBL6984936

SCHEMBL6984936

Nc1nc(N)nc(-c2cnccn2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
ALOX15 P16050 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
GLA P06280 1/20 0.45
HSP90AA1 P07900 2/20 0.44
ADORA2A P29274 3/20 0.40
ADORA1 P30542 2/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
PKM P14618 1/20 0.40
PIK3CD O00329 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PI4KA P42356 1/20 0.39
PIK3CG P48736 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
NISCH Q9Y2I1 1/20 0.37
METAP2 P50579 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8121949 0.85 KDM4E (0.41) KDM4EALOX15L3MBTL1GLAHSP90AA1
SCHEMBL4780009 0.84 NPC1 (0.46) KDM4EGLAHSP90AA1ADORA2AADORA1
SCHEMBL28302590 0.82 KDM4E (0.45) KDM4EALOX15L3MBTL1GLAHSP90AA1
SCHEMBL23647932 0.81 HSP90AA1 (0.48) KDM4EALOX15L3MBTL1GLAHSP90AA1
SCHEMBL27850416 0.77 HSP90AA1 (0.43) KDM4EALOX15L3MBTL1GLAHSP90AA1
Hydrochloric Acid SCHEMBL1367779 0.75 HSP90AA1 (0.41) KDM4EALOX15L3MBTL1GLAHSP90AA1
SCHEMBL17755586 0.74 HTT (0.42) KDM4EL3MBTL1GLAADORA2ANPC1
SCHEMBL13978020 0.74 TP53 (0.44) KDM4EALOX15GLAHSP90AA1ADORA2A
SCHEMBL27877133 0.74 KDM4E (0.45) KDM4EGLAHSP90AA1ADORA2AADORA1
SCHEMBL23647986 0.74 NPC1 (0.41) KDM4EGLAHSP90AA1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed